Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-29 @ 4:50 AM
Study NCT ID:
NCT04857112
Status:
COMPLETED
Last Update Posted:
2025-09-09
First Post:
2021-04-19
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis
Sponsor:
Bausch Health Americas, Inc.
Organization: